Worth reading
44Recurring
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Shares delivered during the month: 0 shares (0 newly issued shares and 0 treasury shares transferred)
発行済株式総数
Exercise ratio during the month: 0.00%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total issued: 18,100 rights; unexercised as of the end of the month preceding the target month: 7,330 rights; unexercised as of the end of the target month: 7,330 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 16 March 2026 / Type Issuance of the 17th Series of Stock Acquisition Rights (with exercise price adjustment provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered during the month: 0 shares (0 newly issued shares and 0 treasury shares transferred) |
| Dilution Rate | Exercise ratio during the month: 0.00% |
| Total number of issued shares | 9,177,000 shares (as of the end of the month preceding the target month) → Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 18,100 rights; unexercised as of the end of the month preceding the target month: 7,330 rights; unexercised as of the end of the target month: 7,330 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 16 March 2026 / Type Issuance of the 17th Series of Stock Acquisition Rights (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 17th Series Stock Acquisition Rights in October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.